ニューヨークにおけるアミロイドーシスの臨床試験
ニューヨーク内の拠点で、アミロイドーシスに関する10件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Icahn School of Medicine at Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Manhasset
- Research Site, New York
- Research Site, New York
- 他1件
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Manhasset
- Clinical Trial Site, New York
- Clinical Trial Site, New York
- 他2件
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/16更新 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, New York
- Clinical Trial Site, New York
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/15更新 · NCT07223203ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, New York
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/08更新 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- Columbia University Medical Center, New York
被験者募集中観察研究
30歳〜80歳 · 全性別 · 2026/08/31更新 · NCT05489549Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- 他1件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, New York
- Research Site, New York
- Research Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/02更新 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Icahn School of Medicine at Mount Sinai /ID# 255408, New York
- Columbia University Medical Center /ID# 255068, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255073, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/13更新 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Columbia University Medical Center, New York
被験者募集中第3相
18歳〜90歳 · 全性別 · 2026/03/27更新 · NCT06128629ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。